Michael G. Grey, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 21,500 shares at $38.26 ($821K) on 2008-03-05, disclosed to the SEC on 2008-03-07.
Open-market sale of $821k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.03 | 800 | $30K | 3.7% |
| 2 | $38.04 | 500 | $19K | 2.3% |
| 3 | $38.05 | 800 | $30K | 3.7% |
| 4 | $38.06 | 1,000 | $38K | 4.6% |
| 5 | $38.07 | 1,600 | $61K | 7.4% |
| 6 | $38.08 | 100 |
| $4K |
| 0.5% |
| 7 | $38.10 | 1,200 | $46K | 5.6% |
| 8 | $38.11 | 1,900 | $72K | 8.8% |
| 9 | $38.13 | 204 | $8K | 0.9% |
| 10 | $38.14 | 1,100 | $42K | 5.1% |
| 11 | $38.15 | 100 | $4K | 0.5% |
| 12 | $38.16 | 1,700 | $65K | 7.9% |
| 13 | $38.17 | 950 | $36K | 4.4% |
| 14 | $38.18 | 443 | $17K | 2.1% |
| 15 | $38.19 | 300 | $11K | 1.4% |
| 16 | $38.20 | 900 | $34K | 4.2% |
| 17 | $38.21 | 900 | $34K | 4.2% |
| 18 | $38.22 | 600 | $23K | 2.8% |
| 19 | $38.23 | 1,100 | $42K | 5.1% |
| 20 | $38.24 | 600 | $23K | 2.8% |
| 21 | $38.25 | 903 | $35K | 4.2% |
| 22 | $38.26 | 200 | $8K | 0.9% |
| 23 | $38.27 | 500 | $19K | 2.3% |
| 24 | $38.30 | 300 | $11K | 1.4% |
| 25 | $38.31 | 1,000 | $38K | 4.7% |
| 26 | $38.33 | 700 | $27K | 3.3% |
| 27 | $38.34 | 500 | $19K | 2.3% |
| 28 | $38.35 | 500 | $19K | 2.3% |
| 29 | $38.36 | 100 | $4K | 0.5% |
| Total | $38.17 avg | 21,500 | $821K | 100% |
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |